Global RNAi Technologies, Markets and Companies Report 2016
Apr 07, 2016 12:52 pm UTC| Business
Dublin, April 07, 2016 -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "RNAi - Technologies, Markets and Companies" to their offering. Various...
TSI Healthcare Ranks Number 1 Worldwide in Customer Service
Apr 07, 2016 12:48 pm UTC| Business
CHAPEL HILL, N.C. , April 07, 2016 -- TSI Healthcare, a national leader in the sales and support of customized NextGen® Practice Management and Electronic Health Record solutions, added another accolade to its growing...
Global Drug Delivery in Cancer Report 2016 - Technologies, Markets and Companies 2015-2025
Apr 07, 2016 12:48 pm UTC| Business
Dublin, April 07, 2016 -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Drug Delivery in Cancer - Technologies, Markets and Companies" to their offering. ...
Collegium Announces Publication of Data on the Durability of Pain Relief with Xtampza ER
Apr 07, 2016 12:43 pm UTC| Business
CANTON, Mass., April 07, 2016 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced the publication of an analysis of the duration of effect of Xtampza™ ER administered every 12 hours during the Double-blind...
Burcon Announces Convertible Note Financing
Apr 07, 2016 12:43 pm UTC| Business
VANCOUVER, British Columbia, April 07, 2016 -- Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BUR) (“Burcon”) announced today that it has entered into a convertible note purchase agreement on April 7, 2016 pursuant to...
Hooker Furniture Reports Operating Profitability Gains in 2016 Fiscal Year
Apr 07, 2016 12:30 pm UTC| Business
MARTINSVILLE, Va., April 07, 2016 -- Hooker Furniture (NASDAQ:HOFT) today reported consolidated net sales of $247 million and net income of $16.2 million, or $1.49 per diluted share, for its fifty-two week fiscal year...
Cellectar Biosciences Receives Positive NASDAQ Listing Determination
Apr 07, 2016 12:30 pm UTC| Business
MADISON, Wis., April 07, 2016 -- Cellectar Biosciences, Inc. (NASDAQ:CLRB) (“Cellectar” or the “company”), an oncology-focused biotechnology company, announced today that on April 6, 2016, the NASDAQ Listing...